Literature DB >> 27863184

Lipase-Sensitive Transfersomes Based on Photosensitizer/Polymerizable Lipid Conjugate for Selective Antimicrobial Photodynamic Therapy of Acne.

Hyung Park1, Jonghwan Lee1, Songhee Jeong1, Byeong Nam Im1, Min-Kyoung Kim2, Su-Geun Yang2, Kun Na1.   

Abstract

Acne vulgaris is a common skin problem affecting nearly 90% of adolescents and its development is associated with a colonization of Propionibacterium acnes (P. acnes). Although antibiotics have commonly been used to treat acne, antibiotic resistance of P. acnes is an emerging issue to be solved. In this study, a new way of photodynamic acne therapy is developed using P. acnes lipase-sensitive transfersome (DSPE-PEG-Pheo A (DPP) transfersome). For enhanced selectivity and skin penetration efficiency, DPP transfersomes are prepared from 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000], pheophorbide A (Pheo A), cholesterol, and Tween-80. Incorporation of Tween-80 as an edge activator increases the deformability of DPP transfersomes, enhancing skin penetration efficiency to four times that of free Pheo A. The photoactivity of Pheo A quenched by DPP transfersomes is gradually recovered by selective cleavage of the ester linkage in DPP transfersomes by P. acnes lipases. In vitro P. acnes-specific photoactivity and subsequent selective antimicrobial effect exhibit a greater than 99% loss of P. acnes viability. In vivo antiacne therapeutic effect is confirmed by reduction of swelling volume and thickness of P. acnes-induced nude mice skin. These results demonstrate that DPP transfersome-mediated photodynamic therapy can be used as an alternative method to treat bacterial skin infections.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  acne; enzyme sensitive; photodynamic therapy; propionibacterium acnes; transfersome

Mesh:

Substances:

Year:  2016        PMID: 27863184     DOI: 10.1002/adhm.201600815

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  7 in total

1.  A Nanocarrier Skin-Targeted Drug Delivery System using an Ascorbic Acid Derivative.

Authors:  Yutaka Inoue; Mitsue Hibino; Isamu Murata; Ikuo Kanamoto
Journal:  Pharm Res       Date:  2017-12-28       Impact factor: 4.200

2.  Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?

Authors:  Girgis Obaid; Shazia Bano; Srivalleesha Mallidi; Mans Broekgaarden; Jerrin Kuriakose; Zachary Silber; Anne-Laure Bulin; Yucheng Wang; Zhiming Mai; Wendong Jin; Diane Simeone; Tayyaba Hasan
Journal:  Nano Lett       Date:  2019-10-04       Impact factor: 11.189

Review 3.  Liposomal formulations of photosensitizers.

Authors:  Sanjana Ghosh; Kevin A Carter; Jonathan F Lovell
Journal:  Biomaterials       Date:  2019-07-10       Impact factor: 12.479

Review 4.  Novel nanomaterial-based antibacterial photodynamic therapies to combat oral bacterial biofilms and infectious diseases.

Authors:  Manlin Qi; Minghan Chi; Xiaolin Sun; Xianju Xie; Michael D Weir; Thomas W Oates; Yanmin Zhou; Lin Wang; Yuxing Bai; Hockin Hk Xu
Journal:  Int J Nanomedicine       Date:  2019-08-28

Review 5.  The Challenge of Nanovesicles for Selective Topical Delivery for Acne Treatment: Enhancing Absorption Whilst Avoiding Toxicity.

Authors:  Antonia Mancuso; Maria Chiara Cristiano; Massimo Fresta; Donatella Paolino
Journal:  Int J Nanomedicine       Date:  2020-11-19

Review 6.  Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies.

Authors:  Nayanika Chakraborty; Diksha Jha; Indrajit Roy; Pradeep Kumar; Shailendra Singh Gaurav; Kalisvar Marimuthu; Oon-Tek Ng; Rajamani Lakshminarayanan; Navin Kumar Verma; Hemant K Gautam
Journal:  J Nanobiotechnology       Date:  2022-08-12       Impact factor: 9.429

Review 7.  Antimicrobial Photodynamic Therapy: Latest Developments with a Focus on Combinatory Strategies.

Authors:  Raphaëlle Youf; Max Müller; Ali Balasini; Franck Thétiot; Mareike Müller; Alizé Hascoët; Ulrich Jonas; Holger Schönherr; Gilles Lemercier; Tristan Montier; Tony Le Gall
Journal:  Pharmaceutics       Date:  2021-11-24       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.